Search

everythinglearnresearchcommunity

for

Search:↓

Higher DHT in male baldness may protect against prostate cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

A new compound was effective for imaging prostate cancer in rats.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Large prostates link to more hair loss.

Finasteride treats hair loss but may affect prostate cancer detection.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.